The Barbados Medicinal Cannabis Licensing Authority (BMCLA) received new industry standards from the Barbados National Standards Institution (BNSI) yesterday to support the local cannabis industry, with the aim to ensure that the medicinal cannabis industry is held to the highest ethical standards.
The strategic partnership between BNSI’s standards, test methods, certification, technical regulation support and training, and the BMCLA’s regulatory oversight of the cannabis industry allows both entities to establish optimal qualities for medicinal cannabis products.
The first deliverable was the testing parameters for raw cannabis material which was developed by the BNSI in collaboration with the BMCLA and technical experts. Raw cannabis material is the primary and fundamental ingredient in the production of medicinal cannabis products.
The other deliverable from BNSI to the BMCLA was a standard for packaging and labelling of medicinal cannabis products.
In the official handover, BMCLA’s Chief Executive Officer (CEO), Dr. Shantal Munro-Knight said, “We have worked with BNSI to develop testing parameters as well as standards for packaging and Labeling. These standards represent an important plank in our efforts to ensure high-quality standards in our industry, building out a culture that fosters consumer trust and confidence that products, produced locally and abroad are safe and efficacious.”